Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > It’s all about clear communication

<< Previous

Bullboard Posts

Next >>

Post by scarlet1967on May 13, 2021 9:40am

119 Views

Post# 33190594

It’s all about clear communication

MONCLER

Have a look at their website, under investor section among others they have investor calculator.

They have a separate website called Pan NASH Initiative to educate patients and doctors about the condition also cleverly educate the investors about their program.

https://pannash.org/

From their latest earning release they have lined up in advance a number of events which they will attend again clever and clear communication.

Upcoming investor conference participation